Arvaya Healthcare last traded at ₹107.10 (2026-10-13). Over the past month the stock moved -15.7%, three months the stock moved +84.7%, year the stock moved +124.4%. Its closing range over 52 weeks is ₹47.72 – ₹134.05, with the latest close 20.1% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1985, Bijoy Hans Ltd offers medical and lifestyle solutions through physical infrastructure and digital platforms.[1]
Business Overview:[1] BHL is mainly engaged in the business of trading in bulk drugs, pharmaceuticals, cosmetics, and investments.
In the latest quarter (Jun 2026), Arvaya Healthcare reported sales of ₹0.10 crore and net profit of ₹-0.89 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.10 | -0.81 | -810.00 | -0.89 | -0.19 |
| Mar 2026 | 0.00 | -0.70 | – | -0.63 | -0.13 |
| Dec 2025 | 0.00 | -0.21 | – | -0.16 | -0.21 |
| Sep 2025 | 0.00 | -0.33 | – | -0.31 | -0.41 |
| Jun 2025 | 0.00 | -0.28 | – | -0.25 | -0.33 |
| Mar 2025 | 0.00 | -0.19 | – | -0.21 | -0.70 |
| Dec 2024 | 0.13 | -0.07 | -53.85 | 0.53 | 1.77 |
| Sep 2024 | 0.06 | -0.17 | -283.33 | -0.14 | -0.47 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -14.3% | +85.7% | -100.0% | -100.0% | -100.0% | -100.0% | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | -130.2% | – | – |
| EPS growth | – | – | – | – | – | -111.9% | – | – |
| OPM % | -283.3% | -53.9% | – | – | – | – | – | -810.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Arvaya Healthcare reported sales of ₹0.00 crore (-100.0%) and net profit of ₹-1.20 crore (-957.1%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.00 | -1.37 | – | -1.20 | -0.25 |
| Mar 2025 | 0.28 | -0.51 | -182.14 | 0.14 | 0.47 |
| Mar 2024 | 0.28 | -0.36 | -128.57 | -0.12 | -0.40 |
| Mar 2023 | 0.30 | -0.52 | -173.33 | -0.44 | -1.47 |
| Mar 2022 | 0.33 | -0.30 | -90.91 | -0.19 | -0.63 |
| Mar 2021 | 0.40 | -0.26 | -65.00 | -0.09 | -0.30 |
| Mar 2020 | 0.49 | -0.25 | -51.02 | -0.05 | -0.17 |
| Mar 2019 | 0.40 | -0.25 | -62.50 | -0.08 | -0.27 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -9.1% | +22.5% | -18.4% | -17.5% | -9.1% | -6.7% | +0.0% | -100.0% |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | -957.1% |
| EPS growth | – | – | – | – | – | – | – | -153.2% |
| OPM % | -62.5% | -51.0% | -65.0% | -90.9% | -173.3% | -128.6% | -182.1% | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Arvaya Healthcare.
Get Free AI Stock Analysis FREE →Bijoy Hans board to consider appointment of Executive Director - scanx.trade
Bijoy Hans Limited Officially Renamed Arvaya Healthcare Limited with Effect from May 11, 2026 - scanx.trade
Bijoy Hans Limited Officially Renamed Arvaya Healthcare Limited with Effect from May 11, 2026 - scanx.trade
Bijoy Hans inks pact to acquire 100% stake in Tec-Pool Solutions
Arvaya Healthcare shares were last quoted at ₹107.10 (-2.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Arvaya Healthcare has a price-to-earnings (P/E) ratio of 399.06 and a price-to-book (P/B) ratio of 10.16. The industry P/E is 33.81.
The 52-week high of Arvaya Healthcare is ₹145.00 and the 52-week low is ₹32.32.
The market capitalisation of Arvaya Healthcare is about ₹613.24 crore.
In the latest quarter (Jun 2026), Arvaya Healthcare reported sales of ₹0.10 crore and net profit of ₹-0.89 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Arvaya Healthcare has a 3-year ROE of -5.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 30.62% of Arvaya Healthcare.
Arvaya Healthcare belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z